Bringing the fundamentals into focus…
Back to UroGen Pharma Ltd.
How UroGen Pharma Ltd. stacks up
URGN · against 397 other Healthcare companies of similar size
Growth
94/ 100
Near the top of its peers.
Ranked #22 of 398 · scores higher than 94% of peers
Bars: peers in each 10-point band of the growth score40 peers with a growth score of 90–100, including URGN · Click a bar to see the companies
Why growth scores 94?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 90% of peers. 3-year revenue growth: 37.6% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 95% of peers. Revenue growth: 100.3% vs peer median 6.1%
Metric by metric
Position: dot = URGN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | URGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 400 reported | 100.3% | 6.2% | 95% | 33% | |
| Earnings per share growthHigher is better · 224 reported | Not reported | 10.1% | — | — | 33% |
| 3-year revenue growthHigher is better · 390 reported | 37.6% | 7.1% | 89% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around URGN| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 2.8B USD | 99 | 51 | |
| 16 | 1.3B USD | 95 | 33 | |
| 22 | 1.6B USD | 94 | 52 | |
| 22 | 1.9B USD | 94 | 32 | |
| 22 | 884M USD | 94 | 75 | |
| 22 | 1.7B USD | 94 | 31 | |
| 26 | 22.1B CNY (≈$3.1B) | 93 | 49 | |
| 26 | 1.7B USD | 93 | 46 | |
| 26 | 1.5B USD | 93 | 32 | |
| 26 | 1.1B USD | 93 | 61 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score